These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 32775456)
1. The RNA-Binding Protein HuR in Digestive System Tumors. Song X; Shi X; Li W; Zhang F; Cai Z Biomed Res Int; 2020; 2020():9656051. PubMed ID: 32775456 [TBL] [Abstract][Full Text] [Related]
2. Human antigen R and drug resistance in tumors. Zhou F; Zhang F; Zhou C; Liang M; Cai Z; Lv H; Li W; Wei X Invest New Drugs; 2019 Oct; 37(5):1107-1116. PubMed ID: 30612309 [TBL] [Abstract][Full Text] [Related]
3. Multiple functions of HuR in urinary tumors. Zhang F; Cai Z; Lv H; Li W; Liang M; Wei X; Zhou F J Cancer Res Clin Oncol; 2019 Jan; 145(1):11-18. PubMed ID: 30370480 [TBL] [Abstract][Full Text] [Related]
4. Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells. Liu H; Song X; Hou J; Zhao Z; Chang J DNA Cell Biol; 2018 Mar; 37(3):210-219. PubMed ID: 29327946 [TBL] [Abstract][Full Text] [Related]
5. Hu antigen R (HuR) multimerization contributes to glioma disease progression. Filippova N; Yang X; Ananthan S; Sorochinsky A; Hackney JR; Gentry Z; Bae S; King P; Nabors LB J Biol Chem; 2017 Oct; 292(41):16999-17010. PubMed ID: 28790173 [TBL] [Abstract][Full Text] [Related]
6. Autotaxin Expression Is Regulated at the Post-transcriptional Level by the RNA-binding Proteins HuR and AUF1. Sun S; Zhang X; Lyu L; Li X; Yao S; Zhang J J Biol Chem; 2016 Dec; 291(50):25823-25836. PubMed ID: 27784781 [TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic overexpression of RNA-binding protein HuR is a marker of poor prognosis in meningioma, and HuR knockdown decreases meningioma cell growth and resistance to hypoxia. Gauchotte G; Hergalant S; Vigouroux C; Casse JM; Houlgatte R; Kaoma T; Helle D; Brochin L; Rech F; Peyre M; Labrousse F; Vallar L; Guéant JL; Vignaud JM; Battaglia-Hsu SF J Pathol; 2017 Aug; 242(4):421-434. PubMed ID: 28493484 [TBL] [Abstract][Full Text] [Related]
8. Current Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and Treatment. Kotta-Loizou I; Vasilopoulos SN; Coutts RH; Theocharis S Neoplasia; 2016 Nov; 18(11):674-688. PubMed ID: 27764700 [TBL] [Abstract][Full Text] [Related]
9. Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis. Wang J; Guo Y; Chu H; Guan Y; Bi J; Wang B Int J Mol Sci; 2013 May; 14(5):10015-41. PubMed ID: 23665903 [TBL] [Abstract][Full Text] [Related]
10. Relationship between HuR and tumor drug resistance. Ma Q; Lu Q; Lei X; Zhao J; Sun W; Huang D; Zhu Q; Xu Q Clin Transl Oncol; 2023 Jul; 25(7):1999-2014. PubMed ID: 36947360 [TBL] [Abstract][Full Text] [Related]
11. Elevated Hu-Antigen Receptor (HuR) Expression is Associated with Tumor Aggressiveness and Poor Prognosis but not with COX-2 Expression in Invasive Breast Carcinoma Patients. Giaginis C; Sampani A; Kotta-Loizou I; Giannopoulou I; Danas E; Politi E; Tsourouflis G; Kouraklis G; Patsouris E; Keramopoulos A; Nakopoulou L; Theocharis S Pathol Oncol Res; 2018 Jul; 24(3):631-640. PubMed ID: 28808873 [TBL] [Abstract][Full Text] [Related]
12. Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells. Tan S; Ding K; Chong QY; Zhao J; Liu Y; Shao Y; Zhang Y; Yu Q; Xiong Z; Zhang W; Zhang M; Li G; Li X; Kong X; Ahmad A; Wu Z; Wu Q; Zhao X; Lobie PE; Zhu T J Biol Chem; 2017 Aug; 292(33):13551-13564. PubMed ID: 28637868 [TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone-dependent dissociation of HuR from PPAR-γ regulates adiponectin expression at the posttranscriptional level. Hwang JS; Lee WJ; Hur J; Lee HG; Kim E; Lee GH; Choi MJ; Lim DS; Paek KS; Seo HG FASEB J; 2019 Jun; 33(6):7707-7720. PubMed ID: 30897345 [TBL] [Abstract][Full Text] [Related]
14. Regulation of Kv11.1 potassium channel C-terminal isoform expression by the RNA-binding proteins HuR and HuD. Gong Q; Stump MR; Zhou Z J Biol Chem; 2018 Dec; 293(51):19624-19632. PubMed ID: 30377250 [TBL] [Abstract][Full Text] [Related]
15. RNA Binding Protein, HuR, Regulates Zhou A; Shi G; Kang GJ; Xie A; Liu H; Jiang N; Liu M; Jeong EM; Dudley SC J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29678826 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of Caspase-2 Translation by the mRNA Binding Protein HuR: A Novel Path of Therapy Resistance in Colon Carcinoma Cells? Eberhardt W; Nasrullah U; Haeussler K Cells; 2019 Jul; 8(8):. PubMed ID: 31366165 [TBL] [Abstract][Full Text] [Related]
17. Emerging role of HuR in inflammatory response in kidney diseases. Shang J; Zhao Z Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):753-763. PubMed ID: 28910975 [TBL] [Abstract][Full Text] [Related]
18. Human antigen R: Exploring its inflammatory response impact and significance in cardiometabolic disorders. Abdelsam SS; Ghanem SK; Zahid MA; Abunada HH; Bader L; Raïq H; Khan A; Parray A; Djouhri L; Agouni A J Cell Physiol; 2024 May; 239(5):e31229. PubMed ID: 38426269 [TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of Hu-Antigen Receptor (HuR) and Cyclooxygenase-2 (COX-2) Expression in Human Malignant and Benign Thyroid Lesions. Giaginis C; Alexandrou P; Delladetsima I; Karavokyros I; Danas E; Giagini A; Patsouris E; Theocharis S Pathol Oncol Res; 2016 Jan; 22(1):189-96. PubMed ID: 26498465 [TBL] [Abstract][Full Text] [Related]
20. SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer. Lachiondo-Ortega S; Rejano-Gordillo CM; Simon J; Lopitz-Otsoa F; C Delgado T; Mazan-Mamczarz K; Goikoetxea-Usandizaga N; Zapata-Pavas LE; García-Del Río A; Guerra P; Peña-Sanfélix P; Hermán-Sánchez N; Al-Abdulla R; Fernandez-Rodríguez C; Azkargorta M; Velázquez-Cruz A; Guyon J; Martín C; Zalamea JD; Egia-Mendikute L; Sanz-Parra A; Serrano-Maciá M; González-Recio I; Gonzalez-Lopez M; Martínez-Cruz LA; Pontisso P; Aransay AM; Barrio R; Sutherland JD; Abrescia NGA; Elortza F; Lujambio A; Banales JM; Luque RM; Gahete MD; Palazón A; Avila MA; G Marin JJ; De S; Daubon T; Díaz-Quintana A; Díaz-Moreno I; Gorospe M; Rodríguez MS; Martínez-Chantar ML Cell Rep; 2024 Mar; 43(3):113924. PubMed ID: 38507413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]